CPH 0.00% 0.9¢ creso pharma limited

Ann: Quarterly Update and Appendix 4C, page-41

  1. 66 Posts.

    But to be fair, it's still a company in it's early stages so we can't really totally rely on customer receipts solely to fund the whole operating side of things..the operating expenses seem to be pretty costly and this could also be seen as an investment for the future if all goes well for production. As for directors salaries, i guess one positive thing to note is that every quarter they receive less and less. Where do start to draw the line if they are getting overpaid..?Just my 2 cents.
 
watchlist Created with Sketch. Add CPH (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.